Correlation Between Spyre Therapeutics and Mustang Bio

Can any of the company-specific risk be diversified away by investing in both Spyre Therapeutics and Mustang Bio at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Spyre Therapeutics and Mustang Bio into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Spyre Therapeutics and Mustang Bio, you can compare the effects of market volatilities on Spyre Therapeutics and Mustang Bio and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Spyre Therapeutics with a short position of Mustang Bio. Check out your portfolio center. Please also check ongoing floating volatility patterns of Spyre Therapeutics and Mustang Bio.

Diversification Opportunities for Spyre Therapeutics and Mustang Bio

0.81

Correlation Coefficient

Spyre Therapeutics  Mustang Bio

Very poor diversification

The 3 months correlation between Spyre and Mustang is 0.81. Overlapping area represents the amount of risk that can be diversified away by holding Spyre Therapeutics and Mustang Bio in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Mustang Bio and Spyre Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Spyre Therapeutics are associated (or correlated) with Mustang Bio. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Mustang Bio has no effect on the direction of Spyre Therapeutics i.e., Spyre Therapeutics and Mustang Bio go up and down completely randomly.

Pair Corralation between Spyre Therapeutics and Mustang Bio

Given the investment horizon of 90 days Spyre Therapeutics is expected to under-perform the Mustang Bio. But the stock apears to be less risky and, when comparing its historical volatility, Spyre Therapeutics is 1.57 times less risky than Mustang Bio. The stock trades about -0.12 of its potential returns per unit of risk. The Mustang Bio is currently generating about 0.12 of returns per unit of risk over similar time horizon. If you would invest  19.00  in Mustang Bio on October 9, 2024 and sell it today you would earn a total of  2.00  from holding Mustang Bio or generate 10.53% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Strong
Accuracy	100.0%
Values	Daily Returns

Spyre Therapeutics  vs.  Mustang Bio

Spyre Therapeutics

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Spyre Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of latest fragile performance, the Stock's basic indicators remain sound and the latest tumult on Wall Street may also be a sign of longer-term gains for the firm shareholders.

Mustang Bio

Risk-Adjusted Performance

1 of 100

Insignificant

Compared to the overall equity markets, risk-adjusted returns on investments in Mustang Bio are ranked lower than 1 (%) of all global equities and portfolios over the last 90 days. In spite of very healthy forward indicators, Mustang Bio is not utilizing all of its potentials. The newest stock price disarray, may contribute to short-term losses for the investors.

Pair Trading with Spyre Therapeutics and Mustang Bio

The main advantage of trading using opposite Spyre Therapeutics and Mustang Bio positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Spyre Therapeutics position performs unexpectedly, Mustang Bio can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Mustang Bio will offset losses from the drop in Mustang Bio's long position.

The idea behind Spyre Therapeutics and Mustang Bio pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the USA ETFs module to find actively traded Exchange Traded Funds (ETF) in USA.